Bharat Biotech's Covid vaccine Covaxin gets emergency use listing from WHO panel
Covaxin
The Technical Advisory Group (TAG), an independent advisory council of the World Health Organization (WHO), has recommended that Bharat Biotech's COVID-19 vaccine Covaxin be given Emergency Use Listing (EUL) designation.
The WHO is now reviewing Covaxin's clinical trial results in order to determine if EUL should be used.
Also read | As WHO delays approval for Covaxin jab, every minute is an eternity for this Indian family
The TAG had requested "further clarifications" from the firm on October 26 in order for Covaxin to undertake a final "risk-benefit assessment" for the vaccine's Emergency Use Listing.
In a tweet, India’s External Affairs Minister Dr S Jaishankar appreciated the decision and said that: "Welcome WHO’s decision to grant Emergency Use Listing to COVAXIN. It facilitates travel for many Indian citizens and contributes to vaccine equity. Also a global recognition to PM Narendra Modi’s vision of an Atmanirbhar Bharat. A Happier Diwali."
Welcome @WHO’s decision to grant Emergency Use Listing to #COVAXIN.
It facilitates travel for many Indian citizens and contributes to vaccine equity.
Also a global recognition to PM @narendramodi’s vision of an #AtmanirbharBharat.
A Happier Diwali.
Watch | Gravitas: Is WHO delaying approval for COVAXIN?
"The Technical Advisory Group of WHO has recommended Emergency Use Listing status for Covaxin," a source said.
)
Sunjay Kapur, Karisma Kapoor's ex husband and industrialist, dead at 53
)
Israel strikes Isfahan nuclear center in Iran, sound of explosions heard near Tehran
)
'They are DEAD now, and it will get worse': Trump warns Iran to 'make a deal' before nothing's left after Israeli strikes
&im=FitAndFill=(700,400))
Ahmedabad plane crash: 7 safety issues previously flagged on Boeing 787-8 Dreamliner
)
Iran Revolutionary Guards Air Force head Amir Ali Hajizadeh killed in Israel's strike | Full list of others who were 'eliminated' by IDF
&im=FitAndFill=(700,400))
Ahmedabad plane crash: What sets Boeing 787 and Airbus A350 apart? A closer look
)
How passenger on seat 11A survived Air India crash in Ahmedabad | WATCH video of miracle survivor
)
Ahmedabad plane crash | Who are 10 crew members who lost their lives in Air India's fatal accident
)
Biggest show-off buy in IPL? Indian all-rounder won titles with CSK and MI without playing a single game with them
)
‘Years of planning, 200 aircraft, 300 munitions’: Israel smuggled drones, weapons into Iran before launching strikes | Inside Operation Rising Lion
&im=FitAndFill=(700,400))
Ahmedabad plane crash: 7 faults that John Barnett flagged in Boeing 787 Dreamliner before committing suicide
)
Ahmedabad plane crash: Kerala govt official suspended, detained for sexist, casteist remarks against victim Ranjitha
&im=FitAndFill=(700,400))
Ahmedabad plane crash: What John Barnett and other whistleblowers warned about Boeing 787 Dreamliner?
)
Sunjay Kapur death: Can a bee sting lead to a heart attack? Doctors weigh in
)
Ahmedabad plane crash: Rajasthan doctor who quit job to start afresh in London, killed along with family
)
Karishma Kapoor's ex-husband Sunjay Kapur's cryptic post resurfaces days before his death: Your time...'
TAG-EUL is an independent advisory committee that advises WHO on whether or not a COVID-19 vaccine should be designated for emergency use under the EUL protocol.
Covaxin has been shown to be effective against symptomatic COVID-19 at 77.8% and 65.2 per cent against the novel Delta variant.
The company announced in June that it has completed the final study of Covaxin effectiveness from Phase 3 studies.
Covaxin from Bharat Biotech and Covishield from AstraZeneca and Oxford University are the two most extensively used vaccinations in India.
(With inputs from agencies)